Gilead Sciences, Inc. (GILD)
151.00
-0.22
(-0.15%)
USD |
NASDAQ |
Sep 04, 16:00
150.90
-0.10
(-0.06%)
Pre-Market: 20:00
Gilead Sciences Cash and Short Term Investments (Annual) : 9.613B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 9.613B |
| December 31, 2024 | 11.57B |
| December 31, 2023 | 8.35B |
| December 31, 2022 | 6.858B |
| December 31, 2021 | 7.405B |
| December 31, 2020 | 8.261B |
| December 31, 2019 | 24.67B |
| December 31, 2018 | 30.95B |
| December 31, 2017 | 26.14B |
| December 31, 2016 | 11.90B |
| December 31, 2015 | 14.61B |
| December 31, 2014 | 10.13B |
| December 31, 2013 | 2.132B |
| December 31, 2012 | 1.862B |
| December 31, 2011 | 9.900B |
| December 31, 2010 | 2.099B |
| December 31, 2009 | 1.657B |
| December 31, 2008 | 1.790B |
| Date | Value |
|---|---|
| December 31, 2007 | 1.172B |
| December 31, 2006 | 936.85M |
| December 31, 2005 | 2.324B |
| December 31, 2004 | 1.254B |
| December 31, 2003 | 707.00M |
| December 31, 2002 | 942.37M |
| December 31, 2001 | 582.85M |
| December 31, 2000 | 512.88M |
| December 31, 1999 | 294.39M |
| December 31, 1998 | 279.94M |
| December 31, 1997 | 322.30M |
| December 31, 1996 | 295.96M |
| December 31, 1995 | 155.66M |
| March 31, 1995 | |
| March 31, 1994 | 114.97M |
| March 31, 1993 | 139.35M |
| March 31, 1992 | 105.42M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 6.611B |
| AbbVie, Inc. | 5.257B |
| Regeneron Pharmaceuticals, Inc. | 8.611B |
| Amgen, Inc. | 9.129B |
| Biogen, Inc. | 3.816B |